Paragon Capital Management Inc Exelixis, Inc. Transaction History
Paragon Capital Management Inc
- $124 Billion
- Q1 2025
A detailed history of Paragon Capital Management Inc transactions in Exelixis, Inc. stock. As of the latest transaction made, Paragon Capital Management Inc holds 47,088 shares of EXEL stock, worth $2.15 Million. This represents 1.4% of its overall portfolio holdings.
Number of Shares
47,088
Previous 49,319
4.52%
Holding current value
$2.15 Million
Previous $1.64 Billion
5.86%
% of portfolio
1.4%
Previous 1.28%
Shares
2 transactions
Others Institutions Holding EXEL
# of Institutions
613Shares Held
257MCall Options Held
1.57MPut Options Held
730K-
Black Rock Inc. New York, NY33.5MShares$1.53 Billion0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA28.7MShares$1.31 Billion0.02% of portfolio
-
Farallon Capital Management LLC San Francisco, CA22.5MShares$1.03 Billion4.78% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny14.8MShares$678 Million0.88% of portfolio
-
State Street Corp Boston, MA11.8MShares$539 Million0.02% of portfolio
About EXELIXIS, INC.
- Ticker EXEL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 321,832,000
- Market Cap $14.7B
- Description
- Exelixis, Inc., an oncology-focused biotechnology company, focuses on the discovery, development, and commercialization of new medicines to treat cancers in the United States. The company's products include CABOMETYX tablets for the treatment of patients with advanced renal cell carcinoma who received prior anti-angiogenic therapy; and COMETRIQ ...